MZMichel J. W. Zaal

Michel J. W. Zaal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michel J. W. Zaal has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • H. J. Völker‐Dieben

    VU University Medical Centre, Amsterdam, The Netherlands

    1 shared publication
  • Hennie J. Völker-Dieben

    Department of Ophthalmology, VU Medical Center, Amsterdam, The Netherlands

    1 shared publication
  • J. D'Amaro

    VU University Medical Centre, Amsterdam, The Netherlands

    1 shared publication
  • Joe D'AMaro

    Department of Ophthalmology, VU Medical Center, Amsterdam, The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Visual prognosis in immunocompetent patients with herpes zoster ophthalmicus

    by M. J. W. Zaal, H. J. Völker‐Dieben, J. D'Amaro

    : Purpose:  To determine the normal spectrum of ocular complications and associated visual outcome in patients with herpes zoster ophthalmicus.Methods:  This prospective observational cohort study included 73 immunocompetent adults with herpes zoster ophthalmicus, referred by their general practitioners within 7 days of skin rash onset. The follow‐up period was 6 months. All patients received a 7–14‐day course of systemic aciclovir treatment combined with longterm application of a lubricating ophthalmic ointment as long as the corneal epithelium was affected. Topical corticosteroids were strictly avoided in the acute phase of ocular disease. Acquired visual loss scores at 1, 2 and 6 months were based on best corrected visual acuity (BCVA) level and evaluation of the ophthalmological history and findings.Results:  Ophthalmic herpes zoster led to a variety of transient inflammatory reactions within the anterior eye segment of the involved side in 46 patients (63%), but did not seriously compromise their ultimate visual outcome. Mild to moderate visual loss, with corrected VA between 0.3 and 0.8, was found in 17 patients at 1 month (23%), in 10 patients at 2 months (14%) and in seven patients at 6 months follow‐up (10%). None of the patients developed visual loss with a corrected VA of less than 0.3.Conclusion:  Functional vision was retained in all ophthalmic zoster patients referred to the ophthalmologist in the acute phase of the disease by vigorous antiviral treatment and adequate prevention of corneal exposure.


  • Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus

    by Michel J. W. Zaal, Hennie J. Völker-Dieben, Joe D'AMaro

    Purpose To determine the prognostic value of nasociliary skin lesions (Hutchinson's sign) for ocular inflammation and corneal sensory denervation in acute herpes zoster ophthalmicus. Methods A longitudinal observational study with a 2-month follow-up was performed involving 83 non-immunocompromised adults with acute herpes zoster ophthalmicus, with a skin rash duration of less than 7 days, referred by their general practitioner. All skin lesions at the tip, the side and the root of the nose, representing the dermatomes of the external nasal and infratrochlear branches of the nasociliary nerve, were documented by taking photographs and marking anatomical drawings. Ocular inflammatory signs were observed by slit-lamp biomicroscopy, and corneal sensitivity was measured with the Cochet–Bonnet esthesiometer at 2-month follow-up. Results Hutchinson's sign was a powerful predictor of ocular inflammation and corneal denervation in herpes zoster ophthalmicus [relative risks: 3.35 (CI 95%: 1.82–6.15) and 4.02 (CI 95%:1.55–10.42), respectively]. The manifestation of herpes zoster skin lesions at the dermatomes of both nasociliary branches was invariably associated with the development of ocular inflammation. Conclusion Clinicians should be alert for early skin lesions within the complete nasociliary dermatome, because they are a reliable prognostic sign of sight-threatening ocular complications in acute herpes zoster ophthalmicus.